Home › Chronic Myeloid Leukemia › Alabama › Birmingham
Chronic Myeloid Leukemia clinical trials in Birmingham, AL
6 studies for Chronic Myeloid Leukemia are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
HPC Offered for PRESERVE Expansion
RecruitingObservational study
- University of Alabama, Birmingham, Birmingham
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
RecruitingPhase 1/2
- University of Alabama Medicine (UAB Medicine), Birmingham
Study of Olverembatinib (HQP1351) in Patients With CML-CP
RecruitingPhase 3
- Ascentage Investigative Site #1044, Birmingham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- University of Alabama at Birmingham, Birmingham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RecruitingPhase 2
- University of Alabama Birmingham, Birmingham
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
RecruitingPhase 1
- University of Alabama at Birmingham, Birmingham
About Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is a cancer of the white blood cells. It usually affects older adults. Learn about symptoms, genetics, and treatment.
More about Chronic Myeloid Leukemia on MedlinePlus
Chronic Myeloid Leukemia trials in other cities
- Houston, TX18 studies
- Seattle, WA11 studies
- New York City, NY10 studies
- Portland, OR7 studies
- Baldwin Park, CA7 studies
- Chicago, IL7 studies
- Detroit, MI6 studies
- Philadelphia, PA6 studies
- St. Louis, MO6 studies
- Milwaukee, WI5 studies
- Nashville, TN5 studies
- Atlanta, GA5 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Ovarian Cancer25 studies
- Breast Cancer24 studies
- Non-Small Cell Lung Cancer23 studies
- Obesity22 studies
- Acute Myeloid Leukemia21 studies
- COPD17 studies
- Multiple Myeloma17 studies
- Cardiovascular Disease16 studies
- Endometrial Cancer16 studies
- Overweight16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.